Share on StockTwits

Imprivata Inc (NASDAQ:IMPR) updated its FY14 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of ($1.18)-(1.10) for the period, compared to the Thomson Reuters consensus estimate of ($0.79), Analyst Ratings.Net reports. The company issued revenue guidance of $91-93 million, compared to the consensus revenue estimate of $90.15 million.Imprivata also updated its Q3 guidance to ($0.17)-(0.14) EPS.

Several analysts have recently commented on the stock. Analysts at Wells Fargo & Co. initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an outperform rating on the stock. On a related note, analysts at William Blair initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an outperform rating on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of Imprivata in a research note on Monday, July 21st. They set an overweight rating and a $19.00 price target on the stock.

Imprivata Inc (NASDAQ:IMPR) traded up 0.55% on Monday, hitting $14.55. 40,152 shares of the company’s stock traded hands. Imprivata Inc has a 52 week low of $13.30 and a 52 week high of $17.49. The stock has a 50-day moving average of $15.82 and a 200-day moving average of $15.82. The company’s market cap is $332.0 million.

Imprivata (NASDAQ:IMPR) last posted its quarterly earnings results on Monday, August 4th. The company reported ($0.81) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.39) by $0.42. The company had revenue of $23.20 million for the quarter, compared to the consensus estimate of $22.15 million. The company’s quarterly revenue was up 34.1% on a year-over-year basis. Analysts expect that Imprivata Inc will post $-0.79 EPS for the current fiscal year.

Imprivata Inc is a provider of authentication and access management technology solutions for the healthcare industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.